CIK 0001512762 · Accelerated filer<br>Smaller reporting company
Coherus Oncology, Inc.
Sign in to watch- Ticker
- CHRS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 273615821
- Phone
- (650) 649-3530
- Business address
- C/O DENNIS M. LANFEAR, 333 TWIN DOLPHIN DR, SUITE 600, REDWOOD CITY, CA, 94065
- Former names
- Coherus BioSciences, Inc., BioGenerics, Inc.
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Other events
- S-8 Other Securities Offered to Employees in Benefit Plans
- S-8 Other Securities Offered to Employees in Benefit Plans
- 4 Open-market sale Chief Operating Officer sold 10,000 shares at an average $19.59 ($195,931)
- 4 Open-market sale Chief Financial Officer sold 6,318 shares at an average $19.85 ($125,424)
- 8-K Event Material agreement
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes President & CEO gave up 21,516 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Scientific Officer gave up 3,477 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 7,077 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Operating Officer gave up 7,146 shares (to pay taxes)
- 4 Option exercise Director acquired 69,994 shares (option exercise)
- SC 13G/A Stake Amended Statement of Ownership
Page 23 of 47 · 923 filings